Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer

The other myeloperoxidase: Emerging functions

(2018) Luc Vanhamme et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Recent Advances in the Treatment of Breast Cancer

(2018) Christy W. S. Tong et al.   Frontiers in Oncology

Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer

(2018) Bin Xu et al.   PATHOLOGY RESEARCH AND PRACTICE

The Genomic Landscape of Male Breast Cancers

(2016) Salvatore Piscuoglio et al.   CLINICAL CANCER RESEARCH

Neutrophil myeloperoxidase and its substrates: formation of specific markers and reactive compounds during inflammation

(2016) Yoji Kato   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Distinct Oral Neutrophil Subsets Define Health and Periodontal Disease States

(2016) N. Fine et al.   JOURNAL OF DENTAL RESEARCH

HMGA1 overexpression is associated with a particular subset of human breast carcinomas

(2015) Romina Sepe et al.   JOURNAL OF CLINICAL PATHOLOGY

Role of the Tumor Microenvironment in Breast Cancer

(2015) Savas D. Soysal et al.   PATHOBIOLOGY

Neutrophils in Cancer: Two Sides of the Same Coin

(2015) Eileen Uribe-Querol et al.   Journal of Immunology Research

Absence of myeloperoxidase and CD8 positive cells in colorectal cancer infiltrates identifies patients with severe prognosis

(2015) Silvio Däster et al.   OncoImmunology

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

(2014) Evgeniy B. Eruslanov et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis

(2014) Meixiao Shen et al.   PLoS One

Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression

(2013) Inbal Mishalian et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic Factor

(2013) Raoul A. Droeser et al.   PLoS One

Effect of ASCO/CAP Guidelines for Determining ER Status on Molecular Subtype

(2012) Brenda Deyarmin et al.   ANNALS OF SURGICAL ONCOLOGY

Tumor-associated neutrophils: friend or foe?

(2012) Z. G. Fridlender et al.   CARCINOGENESIS

Prognostic Impact of Ki-67 Overexpression in Subgroups Categorized according to St. Gallen with Early Stage Breast Cancer

(2012) Nobuaki Matsubara et al.   ONCOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Tumor-Associated Neutrophils: New Targets for Cancer Therapy

(2011) A. D. Gregory et al.   CANCER RESEARCH

Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy

(2011) James P Quigley et al.   Future Oncology

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

(2010) Christophe Ginestier et al.   JOURNAL OF CLINICAL INVESTIGATION

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

(2009) Zvi G. Fridlender et al.   CANCER CELL

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE

Evaluation of a series of bicyclic CXCR2 antagonists

(2007) Iain Walters et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

MMPs as therapeutic targets—Still a viable option?

(2007) B FINGLETON   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY